The European School of Oncology (ESO) is a provider of continuing medical education to oncology professionals, with a particular focus on areas of Central and Eastern Europe and the Balkans region.[1][2]

It is a non-profit organisation, based in Milan, Italy, that is independently funded via two foundations ‒ the ESO Foundation (ESOF) and the Fondazione per la Formazione Oncologica (FFO), primarily through a legacy left to the School by the last surviving members of the family Necchi-Campiglio.[3]

History

The School was founded in 1982 by Umberto Veronesi, an Italian breast surgeon and Scientific Director of the National Cancer Institute of Milan. The concept, first outlined at the 1981 founding congress of the European Society of Surgical Oncology, was for a permanent interdisciplinary and international school, free from non-medical influence, and in line with the medical traditions of the ‘Old Continent’ of Europe, which were seen as distinct from the medical culture in the US, in putting a greater emphasis on the therapeutic importance of the doctor‒patient relationship.[4]

The founding scientific leadership of the School was drawn from a range of oncology disciplines and European countries.[5][6] They included Michael Peckham, a UK-based radiotherapist and co-founder of the European Society for Therapeutic Radiology and Oncology (now European Society for Radiotherapy and Oncology),;[7] Herbert Pinedo, a leader in the emerging specialism of medical oncology, based in the Netherlands, and author of early editions of Cancer Chemotherapy;[8] Franco Cavalli, a Swiss haematologist and founding member of the European Society for Medical Oncology, Louis Denis, a urologist and founder member of the European Organisation for Research and Treatment of Cancer genito-urinary group;[9] and Umberto Veronesi himself, an Italian breast surgeon, who had developed and trialled the quadrantectomy technique for breast conserving surgery [10] and initiated the first trials investigating the impact of adjuvant chemotherapy in operable breast cancer.[11]

Multiprofessional cancer care education

The first ESO oncology course was held in 1982 in the Castello di Pomerio in Lombardy northern Italy, near Milan.[4][5] The teaching faculty comprised most of the School's founders, and the course covered the principles of management of the main cancers from a multidisciplinary standpoint. In its early years the School concentrated on post-graduate courses in medical oncology, which at that time was treated in most of Europe as a branch of internal medicine, rather than a specialism requiring its own curriculum and qualifications.[12] From 2001, the School began to focus much of its work on countries in Central and Eastern Europe and the Balkans region, where survival rates for cancer were markedly lower than in Western Europe and Northern Europe.[2][13] It also started to widen its areas of work to support oncologists at different stages in their careers, starting from the time they leave medical school. In 2002 ESO ran the first five-day Masterclass in Clinical Oncology.[14][15] In 2004 it initiated a summertime Oncology for Medical Students course.[16][17] In 2008 the e-ESO distance learning programme was started, to increase global access to oncology education.[18] In 2012 ESO launched a visiting professors programme, primarily to support clinical institutes in Eastern Europe and the Balkan Region.[2] In 2013 it added a scheme for clinical training fellowships at centres of excellence across Europe,[19] and also set up certificates of competence as specialist qualifications in lymphoma,[20] breast cancer,[21] and gastrointestinal cancer,[22] and a certificate of advanced studies in lung cancer,[23] which run in collaboration with the University of Ulm, the University of Zurich and the Università della Svizzera italiana. In 2020 the School set up the ESO college ESCO,[24] to bring all these different initiatives into a structure that alumni can pursue step by step.

Societies

ESO is a member of the Union for International Cancer Control and the European Cancer Organisation.

Journal

The ESO official journal is Critical Reviews in Oncology/Hematology, which publishes critical reviews in all fields of oncology and hematology, as well as reviews and original research in the field of geriatric oncology.

References

  1. ↑ Ernberg, Ingemar (March 2, 2019). "Education aimed at increasing international collaboration and decreasing inequalities". Molecular Oncology. 13 (3): 648–652. doi:10.1002/1878-0261.12460. PMC 6396351. PMID 30677237.
  2. 1 2 3 "Eniu, Alexandru et al. (2019) Challenging cancer inequalities within Europe through education and training: ESO's vision. Cancer Control 75" (PDF).
  3. ↑ "Sorelle Nedda e Gigina Necchi". November 6, 2017.
  4. 1 2 Apollonio U (ed) (1992) A Decade of Cancer Education and Training in Europe. Milan, Arnoldo Mondadori Editore
  5. 1 2 Wagstaff Anna with Costa Alberto (2012) Learning to Care ESO at 30, European School of Oncology, Milan
  6. ↑ Veronesi Umberto with Costa Alberto (2009) L’uomo dal camice bianco. Rizzoli, Milan
  7. ↑ "History".
  8. ↑ Pinedo, Herbert (1979) Cancer Chemotherapy. Elsevier Science Publishing Company BV. ISBN 9780444900845
  9. ↑ "In memoriam: Prof. Dr. Louis Denis (1933-2021) - Uroweb". Uroweb - European Association of Urology.
  10. ↑ Veronesi, Umberto; Saccozzi, Roberto; Del Vecchio, Marcella; Banfi, Alberto; Clemente, Claudio; De Lena, Mario; Gallus, Giuseppe; Greco, Marco; Luini, Alberto; Marubini, Ettore; Muscolino, Giuseppe; Rilke, Franco; Salvadori, Bruno; Zecchini, Annamaria; Zucali, Roberto (January 13, 2010). "Comparing Radical Mastectomy with Quadrantectomy, Axillary Dissection, and Radiotherapy in Patients with Small Cancers of the Breast". New England Journal of Medicine. 305 (1): 6–11. doi:10.1056/NEJM198107023050102. PMID 7015141.
  11. ↑ Bonadonna, Gianni; Brusamolino, Ercole; Valagussa, Pinuccia; Rossi, Anna; Brugnatelli, Luisa; Brambilla, Cristina; De Lena, Mario; Tancini, Gabriele; Bajetta, Emilio; Musumeci, Renato; Veronesi, Umberto (February 19, 1976). "Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer". New England Journal of Medicine. 294 (8): 405–410. doi:10.1056/NEJM197602192940801. PMID 1246307 – via Taylor and Francis+NEJM.
  12. ↑ "Recognition and Status of Medical Oncology". www.esmo.org.
  13. ↑ "Znaor A, van den Hurk C, Primic-Zakelj M, et al. (2013) Cancer incidence and mortality patterns in South Eastern Europe in the last decade: Gaps persist compared with the rest of Europe. Eur J Cancer 49:1683–1691".
  14. ↑ Pavlidis, Nicholas; Peccatori, Fedro; Aapro, Matti; Eniu, Alexandru; Stahel, Rolf; Cervantes, Andres; Cavalli, Franco; Costa, Alberto (June 1, 2021). "ESO-ESMO Masterclass in Clinical Oncology: Analysis and Evaluation of the Learning Self-Assessment Test". Journal of Cancer Education. 36 (3): 556–560. doi:10.1007/s13187-019-01664-6. PMID 31845109. S2CID 209381347 – via Springer Link.
  15. ↑ Pavlidis, Nicholas; Peccatori, Fedro A.; Aapro, Matti; Eniu, Alex; Kay, Stanley; Rolfo, Christian; Cavalli, Franco; Costa, Alberto (July 1, 2020). "The impact of the European School of Oncology masterclass in clinical oncology on self-professional development". Critical Reviews in Oncology/Hematology. 151: 102976. doi:10.1016/j.critrevonc.2020.102976. PMID 32389896. S2CID 218584575 – via ScienceDirect.
  16. ↑ "Pavlidis, Nicholas et al. (2007) Oncology for Medical Students: an ESO contribution to undergraduate cancer education. Cancer Treat Rev 33(5):419‒426".
  17. ↑ Pavlidis, Nicholas; et al. (January 2, 2021). "ESO-ESSO-ESTRO Multidisciplinary Course in Oncology for Medical Students: 4 Years of Experience (2016–2019)". Journal of Cancer Education. 37 (4): 1239–1244. doi:10.1007/s13187-020-01947-3. PMID 33387267. S2CID 256074346 – via Springer Link.
  18. ↑ "ESO - European School of Oncology". www.e-eso.net.
  19. ↑ Pavlidis, Nicholas; Peccatori, Fedro A; Aapro, Matti; Eniu, Alex; Cavalli, Franco; Costa, Alberto (September 1, 2020). "The clinical training centers fellowships: a European School of Oncology career development program (2013–2019)". Future Oncology. 16 (26): 1969–1976. doi:10.2217/fon-2020-0193. PMID 32567377. S2CID 219972212 – via futuremedicine.com (Atypon).
  20. ↑ "Certificate of Competence - Universität Ulm". www.uni-ulm.de.
  21. ↑ Montagna, Giacomo; Anderson, David; Bochenek-Cibor, Justyna; Bozovic-Spasojevic, Ivana; Campos, Conceicao; Cavallero, Sandro; Durutovic, Ivana; Gomez Cuadra, Manuel Oscar; Irfan, Tazia; Joly, Laetita; Kassem, Loay; Kolben, Theresa M.; Machacek, Martina; Mir Khan, Benazir; Nagvekar, Mayur; Pellegrino, Benedetta; Pogoda, Katarzyna; Câmara, Gabriela Rodrigues; Ferreira, Pedro Santos; Seferi, Melsi; Talibova, Narmin; Van den Rul, Nathalie; Vettus, Elen; Rocco, Nicola (February 2, 2019). "How to become a breast cancer specialist in 2018: The point of view of the second cohort of the Certificate of Competence in Breast Cancer (CCB2)". The Breast. 43: 18–21. doi:10.1016/j.breast.2018.10.006. PMID 30388502. S2CID 53216867.
  22. ↑ "Certificate of Advanced Studies in Gastrointestinal Cancer (CAS-GI)".
  23. ↑ "CAS in Lung Cancer".
  24. ↑ "About ESCO".
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.